Income Statement (TTM)
Shanghai Junshi Biosciences Co., Ltd. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,259 | 1,595 | 3,038 | 3,134 | 3,302 | 4,025 | 3,039 | 2,856 | 2,525 | 1,453 | 1,079 | 1,177 | 1,222 | 1,503 | 1,628 | 1,619 | 1,787 | 1,948 | 2,068 | 2,331 |
| Change (%) | 26.69 | 90.48 | 3.17 | 5.36 | 21.88 | -24.49 | -6.01 | -11.61 | -42.43 | -25.76 | 9.08 | 3.77 | 23.00 | 8.36 | -0.57 | 10.40 | 9.01 | 6.15 | 12.69 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 237 | 377 | 639 | 755 | 918 | 1,258 | 1,142 | 1,109 | 935 | 526 | 447 | 494 | 436 | 634 | 657 | 565 | 623 | 524 | 509 | 555 |
| Change (%) | 59.21 | 69.62 | 18.07 | 21.68 | 37.04 | -9.20 | -2.94 | -15.64 | -43.74 | -15.04 | 10.56 | -11.84 | 45.56 | 3.56 | -13.97 | 10.21 | -15.95 | -2.71 | 8.88 | |
| % of Revenue | 18.80 | 23.62 | 21.04 | 24.07 | 27.80 | 31.26 | 37.59 | 38.82 | 37.05 | 36.21 | 41.43 | 41.99 | 35.68 | 42.22 | 40.35 | 34.91 | 34.85 | 26.87 | 24.63 | 23.80 |
| Gross Operating Profit | 1,022 | 1,218 | 2,399 | 2,380 | 2,384 | 2,767 | 1,897 | 1,748 | 1,589 | 927 | 632 | 683 | 786 | 868 | 971 | 1,054 | 1,164 | 1,425 | 1,559 | 1,776 |
| Change (%) | 19.16 | 96.93 | -0.79 | 0.18 | 16.04 | -31.44 | -7.87 | -9.05 | -41.66 | -31.84 | 8.04 | 15.07 | 10.49 | 11.87 | 8.49 | 10.50 | 22.36 | 9.40 | 13.94 | |
| % of Revenue | 81.20 | 76.38 | 78.96 | 75.93 | 72.20 | 68.74 | 62.41 | 61.18 | 62.95 | 63.79 | 58.57 | 58.01 | 64.32 | 57.78 | 59.65 | 65.09 | 65.15 | 73.13 | 75.37 | 76.20 |
| SG&A | 871 | 1,127 | 1,410 | 1,471 | 1,388 | 1,377 | 1,284 | 1,259 | 1,355 | 1,294 | 1,252 | 1,302 | 1,276 | 1,399 | 1,414 | 1,452 | 1,510 | 1,493 | 1,501 | 1,514 |
| Change (%) | 29.48 | 25.10 | 4.31 | -5.64 | -0.81 | -6.76 | -1.90 | 7.58 | -4.49 | -3.27 | 4.03 | -2.03 | 9.67 | 1.07 | 2.66 | 4.00 | -1.11 | 0.53 | 0.89 | |
| % of Revenue | 69.17 | 70.69 | 46.43 | 46.94 | 42.03 | 34.21 | 42.24 | 44.09 | 53.66 | 89.03 | 116.00 | 110.62 | 104.44 | 93.12 | 86.85 | 89.68 | 84.48 | 76.63 | 72.58 | 64.98 |
| R&D | 1,543 | 1,778 | 2,011 | 2,016 | 1,991 | 2,069 | 2,129 | 2,184 | 2,282 | 2,384 | 2,401 | 2,271 | 2,019 | 1,937 | 1,686 | 1,535 | 1,541 | 1,275 | 1,350 | 1,434 |
| Change (%) | 15.27 | 13.12 | 0.25 | -1.28 | 3.93 | 2.91 | 2.57 | 4.51 | 4.47 | 0.70 | -5.43 | -11.09 | -4.03 | -12.97 | -8.95 | 0.38 | -17.25 | 5.82 | 6.29 | |
| % of Revenue | 122.53 | 111.48 | 66.21 | 64.33 | 60.28 | 51.40 | 70.05 | 76.45 | 90.39 | 164.04 | 222.51 | 192.90 | 165.27 | 128.95 | 103.56 | 94.83 | 86.23 | 65.45 | 65.26 | 61.55 |
| OpEx | 2,663 | 3,290 | 4,046 | 4,228 | 4,284 | 4,711 | 4,582 | 4,578 | 4,597 | 4,216 | 4,068 | 4,057 | 3,729 | 3,979 | 3,811 | 3,586 | 3,669 | 3,302 | 3,376 | 3,514 |
| Change (%) | 23.54 | 22.97 | 4.52 | 1.31 | 9.97 | -2.74 | -0.07 | 0.41 | -8.28 | -3.52 | -0.26 | -8.09 | 6.68 | -4.21 | -5.90 | 2.31 | -9.99 | 2.24 | 4.08 | |
| % of Revenue | 211.54 | 206.28 | 133.17 | 134.90 | 129.72 | 117.05 | 150.75 | 160.28 | 182.07 | 290.09 | 376.97 | 344.69 | 305.29 | 264.79 | 234.06 | 221.52 | 205.28 | 169.49 | 163.25 | 150.76 |
| Operating Income | -1,404 | -1,695 | -1,008 | -1,094 | -981 | -686 | -1,542 | -1,722 | -2,072 | -2,763 | -2,989 | -2,880 | -2,508 | -2,476 | -2,183 | -1,967 | -1,882 | -1,354 | -1,308 | -1,183 |
| Change (%) | 20.71 | -40.55 | 8.56 | -10.29 | -30.09 | 124.81 | 11.64 | 20.34 | 33.34 | 8.18 | -3.63 | -12.93 | -1.27 | -11.84 | -9.87 | -4.36 | -28.04 | -3.39 | -9.55 | |
| % of Revenue | -111.54 | -106.28 | -33.17 | -34.90 | -29.72 | -17.05 | -50.75 | -60.28 | -82.07 | -190.09 | -276.97 | -244.69 | -205.29 | -164.79 | -134.06 | -121.52 | -105.28 | -69.49 | -63.25 | -50.76 |
| Interest Expense | -26 | -29 | -39 | -42 | -38 | -22 | -17 | -13 | -13 | -29 | -33 | -30 | -31 | -29 | -32 | -39 | -42 | -51 | -56 | -66 |
| Change (%) | 11.91 | 31.50 | 8.24 | -10.24 | -41.86 | -24.12 | -21.66 | 1.86 | 122.15 | 12.14 | -8.25 | 2.71 | -6.55 | 11.32 | 20.32 | 7.96 | 22.44 | 9.98 | 16.25 | |
| % of Revenue | -2.09 | -1.84 | -1.27 | -1.33 | -1.14 | -0.54 | -0.55 | -0.45 | -0.52 | -2.02 | -3.05 | -2.57 | -2.54 | -1.93 | -1.98 | -2.40 | -2.35 | -2.64 | -2.73 | -2.82 |
| Net Income | -1,418 | -1,669 | -1,062 | -1,060 | -945 | -721 | -1,495 | -1,643 | -1,924 | -2,386 | -2,533 | -2,471 | -2,198 | -2,283 | -2,023 | -1,931 | -1,803 | -1,281 | -1,233 | -1,049 |
| Change (%) | 17.71 | -36.36 | -0.21 | -10.82 | -23.72 | 107.33 | 9.90 | 17.10 | 24.05 | 6.16 | -2.45 | -11.04 | 3.88 | -11.40 | -4.55 | -6.61 | -28.97 | -3.76 | -14.93 | |
| % of Revenue | -112.60 | -104.62 | -34.96 | -33.81 | -28.62 | -17.91 | -49.18 | -57.51 | -76.18 | -164.16 | -234.74 | -209.92 | -179.95 | -151.97 | -124.25 | -119.28 | -100.90 | -65.75 | -59.61 | -44.99 |
Source: Capital IQ
